-
Founded in:
1996-09-03 -
Country:
China -
Address:
No. 28, Lianzhuang North Road, Xinluo District, Longyan City, Fujian Province -
Tax NO.:
91350800157879471K -
Registered Funds:
67.56 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Xylitol |
This product can supplement calories and improve sugar metabolism. Metabolism in the body does not rely on the participation of insulin, and directly participates in sugar metabolism through cells without increasing blood sugar concentration. In addition, this product also has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids.
More
This product can supplement calories and improve sugar metabolism. Metabolism in the body does not rely on the participation of insulin, and directly participates in sugar metabolism through cells without increasing blood sugar concentration. In addition, this product also has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. |
87-99-0 | 15 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Olmesartan Medoxomil |
2,3-Dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1H-tetrazolyl-5-phenyl)benzyl]imidazole-5-carboxylate, cyclic 2,3-carbonic acid Molecular weight: C29H30N6O6
More
2,3-Dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1H-tetrazolyl-5-phenyl)benzyl]imidazole-5-carboxylate, cyclic 2,3-carbonic acid Molecular weight: C29H30N6O6 |
144689-63-4 | 102 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Olmesartan Medoxomil |
Olmesartan medoxomil is a prodrug that is absorbed and hydrolyzed into olmesartan through the gastrointestinal tract. Olmesartan is a selective angiotensin II type 1 receptor (AT1) antagonist that inhibits the vasoconstriction effect of angiotensin II by blocking the binding of angiotensin II to the AT1 receptor of vascular smooth muscle. Its action is independent of the ATⅡ synthesis pathway and does not affect bradykinin. Olmesartan has a much higher affinity for AT1 receptors than AT2 receptors. Although plasma renin activity increases and circulating angiotensin II concentrations rise, it does not affect its antihypertensive effect.
More
Olmesartan medoxomil is a prodrug that is absorbed and hydrolyzed into olmesartan through the gastrointestinal tract. Olmesartan is a selective angiotensin II type 1 receptor (AT1) antagonist that inhibits the vasoconstriction effect of angiotensin II by blocking the binding of angiotensin II to the AT1 receptor of vascular smooth muscle. Its action is independent of the ATⅡ synthesis pathway and does not affect bradykinin. Olmesartan has a much higher affinity for AT1 receptors than AT2 receptors. Although plasma renin activity increases and circulating angiotensin II concentrations rise, it does not affect its antihypertensive effect. |
144689-63-4 | 102 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cytidine 5'-Diphosphocholine |
It strengthens the function of the brainstem reticular formation, especially the ascending reticular formation excitatory system which is closely related to consciousness; strengthens the function of the vertebral system and improves motor paralysis; improves cerebral circulation and promotes brain metabolism by reducing cerebral blood flow resistance and increasing cerebral blood flow, which has a certain effect on promoting brain function recovery and awakening.
More
It strengthens the function of the brainstem reticular formation, especially the ascending reticular formation excitatory system which is closely related to consciousness; strengthens the function of the vertebral system and improves motor paralysis; improves cerebral circulation and promotes brain metabolism by reducing cerebral blood flow resistance and increasing cerebral blood flow, which has a certain effect on promoting brain function recovery and awakening. |
987-78-0 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-tert-Leucine |
When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions.
More
When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions. |
20859-02-3 | 0 | |
| EDTA-2Na |
When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions.
More
When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions. |
139-33-3 | 18 |